Biomet reports Q3 adjusted net income $107.3M vs. $94.9M last year Reports Q4 revenue $822.5M vs. $771.5M last year. The company said knee sales grew 8.4% worldwide, with U.S. growth of 7.7%. Publicly traded peers of Biomet include Zimmer (ZMH) and Stryker (SYK).
Zimmer Acquires bone void filler maker ETEX Holdings Zimmer Holdings announced that it has acquired the business of ETEX Holdings. The financial terms of the transaction were not disclosed. The acquisition enhances Zimmer's Biologics portfolio of treatments through the addition of ETEX's Beta-bsm, CarriGen, EquivaBone, and Gamma-bsm bone void filler products.